Souraka Tapara Dramani Maman

Publication Activity (10 Years)

Years Active: 2018-2018
Publications (10 Years): 1

Top Topics

Multiple Myeloma

Prognostic Factors

Top Venues

BioMed research international

Beijing Genomics Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Beijing Genomics Institute Sep 16 2019 - Jul 15 2020

China

International Marketing Specialist :: Marketing

Publications

Shuo Li, Xiang-Yu Meng, Souraka Tapara Dramani Maman, Yong-Nong Xiao, Sheng Li
Lenalidomide and Low Dose Dexamethasone Plus Elotuzumab or Carfilzomib for Relapsed or Refractory Multiple Myeloma: A Comparison of Progression-Free Survival with Reconstructed Individual Participant Data. BioMed research international 2018 (2018)